
What We’re Reading: Pain Reliever Pregnancy Warning; COVID-19 Record Increases; Blood Type and COVID-19 Risk
The FDA strengthens its guidance for pain reliever use in pregnant women; the United States sees its greatest increase in coronavirus disease 2019 (COVID-19) cases since August; studies point to association of blood type and COVID-19 risk.
FDA Issues Strengthened Guidelines on Pain Reliever Use Among Pregnant Women
The FDA
US Tops 60,000 COVID-19 Cases for First Time Since August
The United States reported 60,000 new coronavirus disease 2019 (COVID-19) infections for the first time since early August on Thursday, according to
Studies Suggest Association Between Blood Type, COVID-19 Risks
Two studies published in the journal Blood Advance suggest blood type may play a role in the risk of becoming infected with COVID-19 or developing life-threatening complications from the illness, NBC News
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.